Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05478499
What this trial is testing

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 154
Testing effectiveness (Phase 2)Study completedNCT02054481
What this trial is testing

BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab

Who this might be right for
Psoriasis
Boehringer Ingelheim 166
Large-scale testing (Phase 3)Study completedNCT03168256
What this trial is testing

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 528
Not applicableLooking for participantsNCT06987292
What this trial is testing

A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)

Who this might be right for
Psoriasis (PsO)EnthesitisPsoriasis Arthritis+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Large-scale testing (Phase 3)UnknownNCT04839016
What this trial is testing

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 660
Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Large-scale testing (Phase 3)Study completedNCT06588283
What this trial is testing

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

Who this might be right for
PsoriasisObesity
Eli Lilly and Company 281
Early research (Phase 1)Study completedNCT01488201
What this trial is testing

A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07719530
What this trial is testing

Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis

Who this might be right for
Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 60
Post-approval studies (Phase 4)Ended earlyNCT04339595
What this trial is testing

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 47
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Not applicableLooking for participantsNCT07746583
What this trial is testing

Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice

Who this might be right for
Psoriasis
Janssen-Cilag Kft. 100
Testing effectiveness (Phase 2)Study completedNCT04776629
What this trial is testing

A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors

Who this might be right for
PsoriasisInflammationCoronary Artery Disease+1 more
Abcentra 77
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Post-approval studies (Phase 4)Study completedNCT02412644
What this trial is testing

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Psoriasis Treatment Center of Central New Jersey 29
Early research (Phase 1)Study completedNCT02763969
What this trial is testing

Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 357
Not applicableStudy completedNCT05065762
What this trial is testing

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Who this might be right for
Psoriasis
Bristol-Myers Squibb 232
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Early research (Phase 1)UnknownNCT03710681
What this trial is testing

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 16
Next Page